Symposium report download
Download a brief written report of the symposium.
Consulting for Aegerion
Giovanni Ceccarini outlines the characteristics and pathogenesis of lipodystrophy and explains the role of leptin in the disease process, as well as describing the symptoms that should raise suspicion of lipodystrophy in a patient.
Research project for AstraZeneca; speaker fees for Novartis, Lilly and Aegerion; advisory boards for Novo Nordisk Foundation and Novartis
Michael Stumvoll discusses the challenges, goals, and optimal timing of the treatment of generalised and partial lipodystrophy with metreleptin.
This video is intended for health care professionals.
Information for patients and carers can be found here.
Product information on metreleptin is available here.
Adverse reactions should be reported to Aegerion by email: Medinfo.emea@aegerion.com or by telephoning the free phone number: 00800 234 37466
Ferruccio Santini discusses the role of specialist centres in managing lipodystrophy patients, including diagnostic tests performed, and the need for resources and a multidisciplinary team for patient management.
Rebecca Sanders describes the challenges faced by patients with lipodystrophy, highlights the need for increased awareness and education to improve patient care, and provides information on patient support organisations.
Has received personal fees for consultancy, travel or accommodation from Aegerion Pharmaceuticals, Lilly, Novo Nordisk, Sanofi, Servier, and Vitalaire
Read a summary of Camille Vatier’s Meet the Expert session that took place at the 21st European Congress of Endocrinology (ECE) in May 2019.
The report can be downloaded from the ‘Meet the Expert report’ download section below.
Consulting for Aegerion
Giovanni Ceccarini outlines the characteristics and pathogenesis of lipodystrophy and explains the role of leptin in the disease process, as well as describing the symptoms that should raise suspicion of lipodystrophy in a patient.
This video is intended for health care professionals.
Information for patients and carers can be found here.
Product information on metreleptin is available here.
Adverse reactions should be reported to Aegerion by email: Medinfo.emea@aegerion.com or by telephoning the free phone number: 00800 234 37466
Research project for AstraZeneca; speaker fees for Novartis, Lilly and Aegerion; advisory boards for Novo Nordisk Foundation and Novartis
Michael Stumvoll discusses the challenges, goals, and optimal timing of the treatment of generalised and partial lipodystrophy with metreleptin.
Ferruccio Santini discusses the role of specialist centres in managing lipodystrophy patients, including diagnostic tests performed, and the need for resources and a multidisciplinary team for patient management.
Rebecca Sanders describes the challenges faced by patients with lipodystrophy, highlights the need for increased awareness and education to improve patient care, and provides information on patient support organisations.
Has received personal fees for consultancy, travel or accommodation from Aegerion Pharmaceuticals, Lilly, Novo Nordisk, Sanofi, Servier, and Vitalaire
Read a summary of Camille Vatier’s Meet the Expert session that took place at the 21st European Congress of Endocrinology (ECE) in May 2019.
The report can be downloaded from the ‘Meet the Expert report’ download section below.
Watch an internationally renowned faculty discuss the lipodystrophy journey through diagnosis, treatment options and patient experiences. Prof. Ferruccio Santini, Dr Giovanni Ceccarini, Dr Michael Stumvoll and Dr Rebecca Sanders outline the need for management and support by specialised teams to ensure accurate diagnosis, access to treatment and dietary advice, with the aim of reducing early mortality and morbidity in patients with lipodystrophy.
This video is intended for health care professionals.
Information for patients and carers can be found here.
Product information on metreleptin is available here.
Adverse reactions should be reported to Aegerion by email: Medinfo.emea@aegerion.com or by telephoning the free phone number: 00800 234 37466